Ventas, Inc. $VTR Shares Bought by Candriam S.C.A.

Candriam S.C.A. grew its position in Ventas, Inc. (NYSE:VTR) by 163.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 133,228 shares of the real estate investment trust’s stock after purchasing an additional 82,606 shares during the quarter. Candriam S.C.A.’s holdings in Ventas were worth $10,895,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of VTR. Deutsche Bank AG lifted its stake in Ventas by 0.7% during the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after purchasing an additional 27,688 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in Ventas in the fourth quarter valued at approximately $1,335,000. Bank of New York Mellon Corp increased its stake in Ventas by 2.5% in the fourth quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after purchasing an additional 70,459 shares during the last quarter. Elevatus Welath Management raised its holdings in Ventas by 140.4% during the fourth quarter. Elevatus Welath Management now owns 95,031 shares of the real estate investment trust’s stock worth $7,354,000 after purchasing an additional 55,501 shares in the last quarter. Finally, Pensionfund PDN acquired a new stake in Ventas during the fourth quarter worth approximately $4,773,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director owned 28,349 shares in the company, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.53% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on VTR. Barclays assumed coverage on shares of Ventas in a research report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective for the company. Evercore reaffirmed an “outperform” rating and issued a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. KeyCorp lifted their price target on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Royal Bank Of Canada boosted their price target on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Finally, Jefferies Financial Group upped their price objective on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Fourteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Ventas has a consensus rating of “Moderate Buy” and an average target price of $96.17.

Ventas Price Performance

Shares of VTR opened at $90.61 on Monday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a fifty-two week low of $62.82 and a fifty-two week high of $94.60. The firm has a 50-day simple moving average of $86.61 and a 200-day simple moving average of $83.69. The company has a market capitalization of $44.05 billion, a price-to-earnings ratio of 164.75, a price-to-earnings-growth ratio of 1.95 and a beta of 0.70.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue was up 22.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities research analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Ventas’s payout ratio is presently 378.18%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.